|
|
||||||||



*
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121; and
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543
Oncostatin M (OM) is a pleiotropic cytokine produced late in the
activation cycle of T cells and macrophages. In vitro it shares
properties with related proteins of the IL-6 family of cytokines;
however, its in vivo properties and physiological function are as yet
ill defined. We show that administration of OM inhibited bacterial
LPS-induced production of TNF-
and lethality in a dose-dependent
manner. Consistent with these findings, OM potently suppressed
inflammation and tissue destruction in murine models of rheumatoid
arthritis and multiple sclerosis. T cell function and Ab production
were not impaired by OM treatment. Taken together these data indicate
the activities of this cytokine in vivo are antiinflammatory without
concordant immunosuppression.
This article has been cited by other articles:
![]() |
E. Hams, C. S. Colmont, V. Dioszeghy, V. J. Hammond, C. A. Fielding, A. S. Williams, M. Tanaka, A. Miyajima, P. R. Taylor, N. Topley, et al. Oncostatin M Receptor-{beta} Signaling Limits Monocytic Cell Recruitment in Acute Inflammation J. Immunol., August 1, 2008; 181(3): 2174 - 2180. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hamada, A. Sato, T. Hirano, T. Yamamoto, G. Son, M. Onodera, I. Torii, T. Nishigami, M. Tanaka, A. Miyajima, et al. Oncostatin M Gene Therapy Attenuates Liver Damage Induced by Dimethylnitrosamine in Rats Am. J. Pathol., September 1, 2007; 171(3): 872 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chattopadhyay, E. Tracy, P. Liang, O. Robledo, S. Rose-John, and H. Baumann Interleukin-31 and Oncostatin-M Mediate Distinct Signaling Reactions and Response Patterns in Lung Epithelial Cells J. Biol. Chem., February 2, 2007; 282(5): 3014 - 3026. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miyaoka, M. Tanaka, T. Naiki, and A. Miyajima Oncostatin M Inhibits Adipogenesis through the RAS/ERK and STAT5 Signaling Pathways J. Biol. Chem., December 8, 2006; 281(49): 37913 - 37920. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Diveu, E. Venereau, J. Froger, E. Ravon, L. Grimaud, F. Rousseau, S. Chevalier, and H. Gascan Molecular and Functional Characterization of a Soluble Form of Oncostatin M/Interleukin-31 Shared Receptor J. Biol. Chem., December 1, 2006; 281(48): 36673 - 36682. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Weiss, A. L. Samson, B. Niego, P. B. Daniel, and R. L. Medcalf Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo FASEB J, November 1, 2006; 20(13): 2369 - 2371. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cohen, S. Marchand-Adam, V. Lecon-Malas, J. Marchal-Somme, A. Boutten, G. Durand, B. Crestani, and M. Dehoux HGF synthesis in human lung fibroblasts is regulated by oncostatin M Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1097 - L1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Igaz, R. Salvi, J.-P. Rey, M. Glauser, F. P. Pralong, and R. C. Gaillard Effects of Cytokines on Gonadotropin-Releasing Hormone (GnRH) Gene Expression in Primary Hypothalamic Neurons and in GnRH Neurons Immortalized Conditionally Endocrinology, February 1, 2006; 147(2): 1037 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Queen, R. E. Ryan, R. G. Holzer, C. R. Keller-Peck, and C. L. Jorcyk Breast Cancer Cells Stimulate Neutrophils to Produce Oncostatin M: Potential Implications for Tumor Progression Cancer Res., October 1, 2005; 65(19): 8896 - 8904. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Higaki, T Ishihara, N Izumo, M Takatsu, and Y Mizushima Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate Ann Rheum Dis, August 1, 2005; 64(8): 1132 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Morikawa, S. Tamura, K.-i. Minehata, P. J. Donovan, A. Miyajima, and E. Senba Essential Function of Oncostatin M in Nociceptive Neurons of Dorsal Root Ganglia J. Neurosci., February 25, 2004; 24(8): 1941 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Nandakumar, L. Svensson, and R. Holmdahl Collagen Type II-Specific Monoclonal Antibody-Induced Arthritis in Mice: Description of the Disease and the Influence of Age, Sex, and Genes Am. J. Pathol., November 1, 2003; 163(5): 1827 - 1837. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mahboubi, N. C. Kirkiles-Smith, J. Karras, and J. S. Pober Desensitization of Signaling by Oncostatin M in Human Vascular Cells Involves Cytoplasmic Tyr Residue 759 in gp130 but Is Not Mediated by Either Src Homology 2 Domain-containing Tyrosine Phosphatase 2 or Suppressor of Cytokine Signaling 3 J. Biol. Chem., June 27, 2003; 278(27): 25014 - 25023. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Hurst, R. M. McLoughlin, J. Monslow, S. Owens, L. Morgan, G. M. Fuller, N. Topley, and S. A. Jones Secretion of Oncostatin M by Infiltrating Neutrophils: Regulation of IL-6 and Chemokine Expression in Human Mesothelial Cells J. Immunol., November 1, 2002; 169(9): 5244 - 5251. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Ensoli, V Fiorelli, A Lugaresi, D Farina, M DeCristofaro, B Collacchi, D S. Muratori, E Scala, M Di Gioacchino, R Paganelli, et al. Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors {alpha} and {beta}, and interferon {gamma} Multiple Sclerosis, August 1, 2002; 8(4): 284 - 288. [Abstract] [PDF] |
||||
![]() |
P. Repovic and E. N. Benveniste Prostaglandin E2 Is a Novel Inducer of Oncostatin-M Expression in Macrophages and Microglia J. Neurosci., July 1, 2002; 22(13): 5334 - 5343. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. K. de Hooge, F. A. J. van de Loo, M. B. Bennink, D. S. de Jong, O. J. Arntz, E. Lubberts, C. D. Richards, and W. B. van den Berg Adenoviral Transfer of Murine Oncostatin M Elicits Periosteal Bone Apposition in Knee Joints of Mice, Despite Synovial Inflammation and Up-Regulated Expression of Interleukin-6 and Receptor Activator of Nuclear Factor-{kappa}B Ligand Am. J. Pathol., May 1, 2002; 160(5): 1733 - 1743. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mahboubi and J. S. Pober Activation of Signal Transducer and Activator of Transcription 1 (STAT1) Is Not Sufficient for the Induction of STAT1-dependent Genes in Endothelial Cells. COMPARISON OF INTERFERON-gamma AND ONCOSTATIN M J. Biol. Chem., March 1, 2002; 277(10): 8012 - 8021. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Somasundaram, M. Ruehl, B. Schaefer, M. Schmid, R. Ackermann, E. O. Riecken, M. Zeitz, and D. Schuppan Interstitial Collagens I, III, and VI Sequester and Modulate the Multifunctional Cytokine Oncostatin M J. Biol. Chem., January 25, 2002; 277(5): 3242 - 3246. [Abstract] [Full Text] [PDF] |
||||
![]() |
A F Wahl and P M Wallace Oncostatin M in the anti-inflammatory response Ann Rheum Dis, November 1, 2001; 60(90003): iii75 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Kerfoot, E. Raharjo, M. Ho, J. Kaur, S. Serirom, D.-M. McCafferty, A. R. Burns, K. D. Patel, and P. Kubes Exclusive Neutrophil Recruitment with Oncostatin M in a Human System Am. J. Pathol., October 1, 2001; 159(4): 1531 - 1539. [Abstract] [Full Text] |
||||
![]() |
W. Q. Li, F. Dehnade, and M. Zafarullah Oncostatin M-Induced Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinase-3 Genes Expression in Chondrocytes Requires Janus Kinase/STAT Signaling Pathway J. Immunol., March 1, 2001; 166(5): 3491 - 3498. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Langdon, C. Kerr, M. Hassen, T. Hara, A. L. Arsenault, and C. D. Richards Murine Oncostatin M Stimulates Mouse Synovial Fibroblasts in Vitro and Induces Inflammation and Destruction in Mouse Joints in Vivo Am. J. Pathol., October 1, 2000; 157(4): 1187 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boileau, M. Houde, G. Dulude, C. H. Clegg, and C. Perreault Regulation of Extrathymic T Cell Development and Turnover by Oncostatin M J. Immunol., June 1, 2000; 164(11): 5713 - 5720. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, O. Robledo, E. Kinzie, F. Blanchard, C. Richards, A. Miyajima, and H. Baumann Receptor Subunit-specific Action of Oncostatin M in Hepatic Cells and Its Modulation by Leukemia Inhibitory Factor J. Biol. Chem., August 11, 2000; 275(33): 25273 - 25285. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Hermanns, S. Radtke, F. Schaper, P. C. Heinrich, and I. Behrmann Non-redundant Signal Transduction of Interleukin-6-type Cytokines. THE ADAPTER PROTEIN Shc IS SPECIFICALLY RECRUITED TO THE ONCOSTATIN M RECEPTOR J. Biol. Chem., December 22, 2000; 275(52): 40742 - 40748. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |